{"id":"aerolef","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The liposome-encapsulated formulation of AeroLEF allows for targeted delivery of budesonide to the lungs, reducing systemic side effects and increasing local efficacy. This targeted delivery enables AeroLEF to effectively reduce inflammation in the lungs, making it a potential treatment for various respiratory conditions.","oneSentence":"AeroLEF is a liposome-encapsulated formulation of budesonide, a corticosteroid that reduces inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:20:10.926Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of acute asthma exacerbations"}]},"trialDetails":[{"nctId":"NCT00794209","phase":"PHASE1","title":"Study Evaluating Inhaled AeroLEF Delivered in 4 Aerosol Delivery Devices in Healthy Volunteers","status":"COMPLETED","sponsor":"YM BioSciences","startDate":"2003-03","conditions":"Healthy","enrollment":9},{"nctId":"NCT00791804","phase":"PHASE2","title":"Phase II Study of Inhaled AeroLEF for Analgesia After ACL Knee Surgery","status":"COMPLETED","sponsor":"YM BioSciences","startDate":"2004-02","conditions":"Pain, Post Operative Pain","enrollment":19},{"nctId":"NCT00709254","phase":"PHASE1","title":"Study of Single and Multiple Doses of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Healthy Subjects","status":"COMPLETED","sponsor":"YM BioSciences","startDate":"2001-12","conditions":"Healthy","enrollment":12},{"nctId":"NCT00708318","phase":"PHASE1","title":"Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects","status":"COMPLETED","sponsor":"YM BioSciences","startDate":"2001-10","conditions":"Healthy","enrollment":6},{"nctId":"NCT00286065","phase":"PHASE2","title":"Study to Determine Efficacy and Safety of Inhaled AeroLEF in the Treatment of Acute Post-op Pain in Adult Patients Undergoing Elective Orthopedic Surgery","status":"COMPLETED","sponsor":"YM BioSciences","startDate":"2006-01","conditions":"Pain","enrollment":123}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Liposome-Encapsulated Fentanyl"],"phase":"phase_2","status":"active","brandName":"AeroLEF","genericName":"AeroLEF","companyName":"YM BioSciences","companyId":"ym-biosciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AeroLEF is a liposome-encapsulated formulation of budesonide, a corticosteroid that reduces inflammation. Used for Treatment of acute asthma exacerbations.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}